echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Luye Pharma's goserelin microsphere preparation for the treatment of stage III prostate cancer reaches the preset end point

    Luye Pharma's goserelin microsphere preparation for the treatment of stage III prostate cancer reaches the preset end point

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On September 6, Luye Pharma announced that its self-developed anti-tumor innovative preparation-Goserelin Acetate Sustained Release Microspheres for Injection (LY01005) has completed a phase III clinical study for the treatment of prostate cancer in China, reaching the preset end point
    .

    The Phase III clinical trial of LY01005 is a randomized, open, positive drug-controlled clinical study to evaluate the effectiveness and safety of continuous intramuscular injection of LY01005 in the treatment of prostate cancer patients
    .


    The trial was randomized to receive LY01005 or control drug treatment at a ratio of 1:1, 3.


    Phase III study results show that: LY01005 is injected intramuscularly once every 28 days at a dose of 3.


    In addition to the field of prostate treatment, LY01005's phase III clinical study for the treatment of breast cancer in China is also underway


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.